title: CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model.
abstract: Demyelination in the central nervous system (CNS) is known to involve several immune effector mechanisms, including complement proteins. Local production of complement by glial cells in the brain can be both harmful and protective. To investigate the roles of C3a and C5a in demyelination and remyelination pathology we utilized the cuprizone model. Transgenic mice expressing C3a or C5a under the control of the glial fibrillary acidic protein (GFAP) promoter had exacerbated demyelination and slightly delayed remyelination in the corpus callosum compared to WT mice. C3a and C5a transgenic mice had increased cellularity in the corpus callosum due to increase activation and/or migration of microglia. Oligodendrocytes migrated to the corpus callosum in higher numbers during early remyelination events in C3a and C5a transgenic mice, thus enabling these mice to remyelinate as effectively as WT mice by the end of the 10 week study. To determine the effects of C3a and/or C5a on individual glial subsets, we created murine recombinant C3a and C5a proteins. When microglia and mixed glial cultures were stimulated with C3a and/or C5a, we observed an increase in the production of proinflammatory cytokines and chemokines. In contrast, astrocytes had decreased cytokine and chemokine production in the presence of C3a and/or C5a. We also found that the MAPK pathway proteins JNK and ERK1/2 were activated in glia upon stimulation with C3a and C5a. Overall, our findings show that although C3a and C5a production in the brain play a negative role during demyelination, these proteins may aid in remyelination.
authors.affiliation: Interdisciplinary Graduate Program in Immunology, University of Iowa, 357 Medical Research Center, Iowa City, IA 52242, USA. sarah-ingersoll@uiowa.edu
authors.forename: Sarah A
authors.initials: SA
authors.lastname: Ingersoll
authors.forename: Carol B
authors.initials: CB
authors.lastname: Martin
authors.forename: Scott R
authors.initials: SR
authors.lastname: Barnum
authors.forename: Brian K
authors.initials: BK
authors.lastname: Martin
mesh_terms: D000818:Animals; D001253:Astrocytes / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D001921:Brain / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D015926:Complement C3a / Q000276:immunology* / Q000378:metabolism; D015936:Complement C5a / Q000276:immunology* / Q000378:metabolism; D003471:Cuprizone / Q000633:toxicity; D003711:Demyelinating Diseases / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D004797:Enzyme-Linked Immunosorbent Assay; D007150:Immunohistochemistry; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D017628:Microglia / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008996:Monoamine Oxidase Inhibitors / Q000633:toxicity; D015213:Neuroimmunomodulation / Q000187:drug effects / Q000276:immunology*; D009836:Oligodendroglia / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D015398:Signal Transduction / Q000276:immunology
chemical_list: D008996:Monoamine Oxidase Inhibitors; D003471:Cuprizone; D015926:Complement C3a; D015936:Complement C5a
references.citation: J Neuroinflammation. 2006 Apr 04;3:8
references.pmid: 16594997
references.citation: Neuroscience. 1999;88(4):1073-82
references.pmid: 10336122
references.citation: Mol Immunol. 2009 Sep;46(14):2753-66
references.pmid: 19477527
references.citation: Biochim Biophys Acta. 2003 Jan 31;1609(2):127-43
references.pmid: 12543373
references.citation: Eur J Immunol. 2002 Apr;32(4):1157-63
references.pmid: 11932923
references.citation: J Immunol. 2009 Jul 15;183(2):1375-83
references.pmid: 19561098
references.citation: Annu Rev Immunol. 2005;23:683-747
references.pmid: 15771584
references.citation: Annu Rev Immunol. 2005;23:821-52
references.pmid: 15771587
references.citation: FEBS Lett. 2003 Feb 27;537(1-3):17-22
references.pmid: 12606024
references.citation: J Neuroimmunol. 2003 Mar;136(1-2):84-93
references.pmid: 12620646
references.citation: J Neurochem. 1998 Feb;70(2):699-707
references.pmid: 9453564
references.citation: Neuroscience. 1996 Aug;73(4):1091-107
references.pmid: 8809827
references.citation: Lupus. 2010 Jan;19(1):73-82
references.pmid: 19900981
references.citation: Am J Pathol. 1997 Jan;150(1):31-41
references.pmid: 9006319
references.citation: Annu Rev Immunol. 1994;12:775-808
references.pmid: 8011297
references.citation: J Neurol Sci. 1996 Dec;144(1-2):135-41
references.pmid: 8994115
references.citation: J Neurosci Res. 1990 Sep;27(1):36-42
references.pmid: 2254955
references.citation: Glia. 2000 Mar;30(1):1-10
references.pmid: 10696139
references.citation: J Neurosci Res. 1990 Nov;27(3):400-7
references.pmid: 2097382
references.citation: Neurochem Res. 2008 Dec;33(12):2615-28
references.pmid: 18661234
references.citation: J Neurosci. 2003 Aug 20;23(20):7710-8
references.pmid: 12930811
references.citation: J Neuroimmunol. 2010 Apr 15;221(1-2):46-52
references.pmid: 20207017
references.citation: J Cell Biochem. 1999 Jun 1;73(3):303-11
references.pmid: 10321830
references.citation: Brain Pathol. 2001 Jan;11(1):107-16
references.pmid: 11145196
references.citation: Immunol Res. 2007;37(3):161-75
references.pmid: 17873401
references.citation: Brain Res. 1987 Nov 3;425(1):186-90
references.pmid: 3427420
references.citation: Glia. 2006 May;53(7):688-95
references.pmid: 16482523
references.citation: Neurosci Lett. 2005 Oct 21;387(2):68-71
references.pmid: 16085360
references.citation: J Neurol Sci. 1987 Apr;78(2):125-37
references.pmid: 3553434
references.citation: J Cell Biol. 1980 Jun;85(3):890-902
references.pmid: 6248568
references.citation: J Immunol. 2004 Oct 1;173(7):4708-14
references.pmid: 15383607
references.citation: Acta Neurol Scand Suppl. 2008;188:72-6
references.pmid: 18439226
references.citation: Brain Res Mol Brain Res. 2003 Apr 10;112(1-2):53-60
references.pmid: 12670702
references.citation: J Immunol. 2008 Dec 15;181(12):8727-34
references.pmid: 19050293
references.citation: Gene Ther. 2000 Jun;7(12):1034-8
references.pmid: 10871752
references.citation: Nat Neurosci. 2010 Mar;13(3):319-26
references.pmid: 20154684
references.citation: J Immunol. 2008 Sep 1;181(5):3167-76
references.pmid: 18713987
references.citation: J Immunol. 1998 Apr 1;160(7):3543-54
references.pmid: 9531317
references.citation: Clin Exp Immunol. 2009 Feb;155(2):128-39
references.pmid: 19040603
references.citation: EMBO J. 2006 Mar 22;25(6):1364-74
references.pmid: 16498410
references.citation: J Neuropathol Exp Neurol. 2004 May;63(5):499-509
references.pmid: 15198128
references.citation: Ann Neurol. 2000 Jun;47(6):707-17
references.pmid: 10852536
references.citation: J Neuroimmunol. 2004 Jun;151(1-2):195-200
references.pmid: 15145618
references.citation: Cerebellum. 2009 Sep;8(3):163-74
references.pmid: 19259754
references.citation: J Virol. 1999 Jan;73(1):205-13
references.pmid: 9847323
references.citation: Mol Cell Neurosci. 1998 Nov;12(4-5):220-7
references.pmid: 9828087
references.citation: J Neurosci. 2001 Sep 15;21(18):7046-52
references.pmid: 11549714
references.citation: Annu Rev Neurosci. 2008;31:247-69
references.pmid: 18558855
references.citation: J Neuroinflammation. 2008 Jan 29;5:5
references.pmid: 18230183
references.citation: J Immunol. 2001 Sep 1;167(5):2964-71
references.pmid: 11509646
references.citation: J Neurosci Res. 2000 Aug 1;61(3):251-62
references.pmid: 10900072
references.citation: Glia. 2007 Nov 1;55(14):1405-15
references.pmid: 17674370
references.citation: Neurosci Lett. 2005 Dec 30;390(3):134-8
references.pmid: 16154690
references.citation: FASEB J. 2003 Dec;17(15):2266-8
references.pmid: 14563692
references.citation: J Neuroimmunol. 1999 Oct 29;99(2):195-204
references.pmid: 10505975
references.citation: Glia. 1999 May;26(3):201-11
references.pmid: 10340761
references.citation: Stem Cells. 2009 Nov;27(11):2824-32
references.pmid: 19785034
references.citation: Glia. 2008 Apr 15;56(6):686-98
references.pmid: 18293407
references.citation: Brain. 2009 Feb;132(Pt 2):288-95
references.pmid: 18567623
references.citation: J Neurochem. 2005 Mar;92(5):1140-9
references.pmid: 15715664
references.citation: Nat Neurosci. 2001 Nov;4(11):1116-22
references.pmid: 11600888
references.citation: J Neuroimmunol. 1998 Dec 1;92(1-2):38-49
references.pmid: 9916878
references.citation: Brain Res. 2001 Mar 16;894(2):321-6
references.pmid: 11251209